Stage III Bladder Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Platinum (DB12257)

IndicationStatusPhase
DBCOND0109731 (Stage III Bladder Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03617913Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder CancerTreatment